This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
OBJECTIVES. Infantile hemangiomas are the most common tumor of infancy. Risk factors for complications and need for treatment have not been studied previously in a large prospective study. This study aims to identify clinical characteristics associated with complications and the need for therapeutic intervention.
PATIENTS AND METHODS. We conducted a prospective cohort study at 7 US pediatric dermatology clinics with a consecutive sample of 1058 children, aged ≤12 years, with infantile hemangiomas enrolled between September 2002 and October 2003. A standardized questionnaire was used to collect data on each patient and each hemangioma, including clinical characteristics, complications, and treatment.
RESULTS. Twenty-four percent of patients experienced complications related to their hemangioma(s), and 38% of our patients received some form of treatment during the study period. Hemangiomas that had complications and required treatment were larger and more likely to be located on the face. Segmental hemangiomas were 11 times more likely to experience complications and 8 times more likely to receive treatment than localized hemangiomas, even when controlled for size.
CONCLUSIONS. Large size, facial location, and/or segmental morphology are the most important predictors of poor short-term outcomes as measured by complication and treatment rates.
- Accepted April 10, 2006.
- Copyright © 2006 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- The 'Pink herring
- PHACE syndrome: importance of distinguishing infantile haemangioma from capillary malformation
- Neonatal intrathoracic haemangioma
- Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma
- Skin Lesions in a Preterm Infant
- Inheritance Patterns of Infantile Hemangioma
- Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial Cells
- Diagnosis and Management of Infantile Hemangioma
- Update on Propranolol for Infantile Hemangioma: Where Are We Now?
- Incidence and treatment of infantile haemangioma in preterm infants
- Dicer Knockdown Inhibits Endothelial Cell Tumor Growth via MicroRNA 21a-3p Targeting of Nox-4
- Infantile haemangiomas and quality of life
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
- Infantile Hemangiomas: An Update on Pathogenesis and Therapy
- Preterm Infant With a Flat, Erythematous Patch
- Early Growth of Infantile Hemangiomas: What Parents' Photographs Tell Us
- Association of Lower Body Cutaneous Hemangiomas & Anomalies
- Question 3 Is what we tell parents about strawberry naevi correct?
- Infantile haemangioma: harmless 'strawberry' or life-threatening vascular anomaly?
- Growth Characteristics of Infantile Hemangiomas: Implications for Management
- Predicting complications of infantile hemangiomas